2021 Revenues ($USD) : $4,164,034,848
2021 Revenues (foreign currencies) : RMB26,861,356,000
2021 R&D spend : $570,046,971
2021 Number of Employees : 25,579
Fiscal Year End : 12/31/2021
Leader : CEO Li Yi

Sino Biopharm is a research-driven pharmaceutical conglomerate based in mainland China. The company markets various biopharmaceutical and chemical medicines for treating tumors, liver diseases, orthopedic diseases, infections, respiratory system diseases and more. The core business in the group is the ChiaTai Tianqing Pharmaceutical Group. Sino Biopharm also developes modernized Chinese medicine as well as biopharma products. The company was founded in 2000. —BB